Search Results - "Lui, Goldie Y.L."
-
1
The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways
Published in Antioxidants & redox signaling (10-03-2013)“…The metastasis suppressor gene, N-myc downstream regulated gene-1 (NDRG1), is negatively correlated with tumor progression in multiple neoplasms, including…”
Get more information
Journal Article -
2
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Published in Oncotarget (07-08-2015)“…Newer and more potent therapies are urgently needed to effectively treat advanced cancers that have developed resistance and metastasized. One such strategy is…”
Get full text
Journal Article -
3
RAB27A promotes melanoma cell invasion and metastasis via regulation of pro‐invasive exosomes
Published in International journal of cancer (15-06-2019)“…Despite recent advances in targeted and immune‐based therapies, advanced stage melanoma remains a clinical challenge with a poor prognosis. Understanding the…”
Get full text
Journal Article -
4
BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer
Published in EBioMedicine (01-10-2020)“…Homologous recombination deficiencies (HRD) are present in approximately half of epithelial ovarian cancers, for which PARP inhibitors (PARPi) are becoming a…”
Get full text
Journal Article -
5
CDK12: an emerging therapeutic target for cancer
Published in Journal of clinical pathology (01-11-2018)“…Cyclin-dependent kinase 12 (CDK12) belongs to the cyclin-dependent kinase (CDK) family of serine/threonine protein kinases that regulate transcriptional and…”
Get more information
Journal Article -
6
Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer
Published in Oncogene (01-05-2019)“…The CDK4/6 inhibitor palbociclib reduces tumor growth by decreasing retinoblastoma (RB) protein phosphorylation and inducing cell cycle arrest at the G1/S…”
Get full text
Journal Article -
7
Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma
Published in Molecular cancer therapeutics (01-04-2021)“…Ovarian clear cell carcinoma (OCCC) is a rare, chemo-resistant subtype of ovarian cancer. To identify novel therapeutic targets and combination therapies for…”
Get full text
Journal Article -
8
Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells
Published in Journal of investigative dermatology (01-07-2016)“…The tumor microenvironment is characterized by cancer cell subpopulations with heterogeneous cell cycle profiles. For example, hypoxic tumor zones contain…”
Get full text
Journal Article -
9
Abrogation of RAB27A expression transiently affects melanoma cell proliferation
Published in Pigment cell and melanoma research (01-11-2020)“…The role of the small GTPase RAB27A as an essential melanosome trafficking regulator in melanocytes is well‐accepted. A decade ago, RAB27A was identified as a…”
Get full text
Journal Article -
10
Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion
Published in Molecular pharmacology (2015)“…Pharmacologic manipulation of metal pools in tumor cells is a promising strategy for cancer treatment. Here, we reveal how the iron-binding ligands…”
Get more information
Journal Article